Protagonist Therapeutics, Inc Share Price
NASDAQ: PTGXHealthcare
Live Protagonist Therapeutics, Inc Share Price Chart
O H L
Protagonist Therapeutics, Inc Performance Overview
Days Range
▼
$141.65Low
$142.16High
Markets Today
| Previous Close | $143.70 |
|---|---|
| Open | $142.16 |
| Volume | 70,532 |
| Day's Range | $141.65 - $142.16 |
| 52W Range | $58.91 - $160.81 |
| Market Cap | $9.24 B |
Historical Performance
| 1M Returns | -8.67 |
|---|---|
| 3M Returns | +27.33 |
| 6M Returns | +48.01 |
| 1Y Returns | +131.25 |
| 5Y Returns | +719.74 |
| 10Y Returns | +851.66 |
Protagonist Therapeutics, Inc Fundamentals
| Market Cap | $9.24 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 137.73 |
| PEG Ratio | N/A |
| Revenue | $46.02 M |
| ROE TTM | -0.20 |
| EPS TTM | $1.04 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 10.98 |
| EBITDA | $-156.85 M |
| Profit Margin | -282.83 |
| Market Cap | $9.24 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 137.73 |
| PEG Ratio | N/A |
| Revenue | $46.02 M |
| ROE TTM | -0.20 |
| EPS TTM | $1.04 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 10.98 |
| EBITDA | $-156.85 M |
| Profit Margin | -282.83 |
Protagonist Therapeutics, Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $28.32 M | $5.55 M | $4.71 M | $7.44 M | $56.37 M | $213.47 M |
| Gross Profit + | $28.32 M | $5.55 M | $4.71 M | $7.44 M | $56.37 M | $213.47 M |
| Operating Income | -$19.31 M | -$42.04 M | -$46.42 M | -$50.35 M | -$3.65 M | $158.77 M |
| EBITDA | -$19.07 M | -$42.04 M | -$46.06 M | -$49.98 M | -$3.24 M | $158.77 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $239.00 K | $0 | $361.00 K | $376.00 K | $407.00 K | $0 |
| Income Before Tax | -$11.65 M | -$34.60 M | -$39.34 M | -$43.72 M | $2.28 M | $165.11 M |
| Income Tax Expense | $0 | $172.00 K | $0 | $666.00 K | -$1.50 M | $2.27 M |
| Net Income + | -$11.65 M | -$34.77 M | -$39.34 M | -$44.38 M | $3.78 M | $162.85 M |
| Net Profit Margin | -41.15% | -626.96% | -834.87% | -596.8% | 6.71% | 76.28% |
Protagonist Therapeutics, Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.00 K | $1.00 K | $1.00 K | $1.00 K | $1.00 K | $1.00 K |
| Reserve & Surplus | -$352.09 M | -$386.96 M | -$425.76 M | -$470.03 M | -$467.16 M | -$304.87 M |
| Non-Current Liabilities | $17.97 M | $14.48 M | $11.31 M | $8.04 M | $7.44 M | $6.82 M |
| Current Liabilities | $35.11 M | $35.51 M | $44.94 M | $45.44 M | $34.55 M | $37.18 M |
| Total Liabilities | $53.08 M | $49.99 M | $56.25 M | $53.48 M | $41.99 M | $44.00 M |
| Fixed Assets | $3.53 M | $4.11 M | $4.10 M | $3.86 M | $3.78 M | $3.46 M |
| Current Assets | $605.86 M | $602.53 M | $586.42 M | $577.57 M | $613.46 M | $807.15 M |
| Total Assets | $742.13 M | $718.01 M | $701.69 M | $668.19 M | $697.46 M | $885.54 M |
Protagonist Therapeutics, Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$11.65 M | $0 | -$39.34 M | -$44.38 M | $3.78 M | $0 |
| Operating Cash Flow | $125.36 M | $0 | -$1.94 M | -$36.98 M | -$48.94 M | $0 |
| Investing Cash Flow | -$94.40 M | $0 | -$58.55 M | $48.81 M | $90.89 M | $0 |
| Financing Cash Flow | $11.44 M | $0 | $5.66 M | $2.84 M | $23.37 M | $0 |
| Change in Cash | $42.40 M | $0 | -$54.83 M | $14.68 M | $65.32 M | $0 |
Protagonist Therapeutics, Inc Return Calculator
The Protagonist Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$79,852
Invested Amount$10,000
Est. Returns$69,852
About Protagonist Therapeutics, Inc
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Popular Stocks
FAQs
What is the share price of Protagonist Therapeutics, Inc today?
Protagonist Therapeutics, Inc (PTGX) share price as of September 18, 2026 is $139.98. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Protagonist Therapeutics, Inc?
Yes, Indian Investors can invest in the Protagonist Therapeutics, Inc (PTGX) Share by opening an international trading account with Angel One.
How can I purchase Protagonist Therapeutics, Inc shares in India?
Purchasing Protagonist Therapeutics, Inc (PTGX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Protagonist Therapeutics, Inc (PTGX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Protagonist Therapeutics, Inc?
Yes, you can purchase fractional shares of Protagonist Therapeutics, Inc (PTGX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Protagonist Therapeutics, Inc?
The market capitalization of Protagonist Therapeutics, Inc on September 18, 2026, is $9.24 B.
In which sector Protagonist Therapeutics, Inc belongs?
Protagonist Therapeutics, Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Protagonist Therapeutics, Inc stocks?
In order to invest in Protagonist Therapeutics, Inc (PTGX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
